
Keywords: Advanced therapy medicinal products; Cell therapy; Clinical trials; Marketing authorisation; Preclinical testing; Tumourigenicity; ADME; Absorption, distribution, metabolism & excretion; MHRA; Medicines & Healthcare products Regulatory Agency; WHO; World